New results in te chemotherapy of mycobacterioses.
D000818:Animals; D003707:Demeclocycline / Q000627:therapeutic use; D004195:Disease Models, Animal; D004338:Drug Combinations; D004977:Ethambutol / Q000627:therapeutic use; D005000:Ethionamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D007538:Isoniazid / Q000627:therapeutic use; D051379:Mice; D009164:Mycobacterium Infections / Q000188:drug therapy* / Q000473:pathology; D010670:Phenylthiourea / Q000031:analogs & derivatives / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use*; D018805:Sepsis; D013449:Sulfonamides / Q000627:therapeutic use; D013623:Tail / Q000473:pathology
D004338:Drug Combinations; D011719:Pyrazines; D013449:Sulfonamides; D003707:Demeclocycline; D010670:Phenylthiourea; D004977:Ethambutol; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin